SEARCH

SEARCH BY CITATION

References

  • Allan S. M. (2002) Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system. J. Neurosci. Res. 67, 428434.
  • Allan S. M., Tyrrell P. J. and Rothwell N. J. (2005) Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629640.
  • Benveniste E. N., Sparacio S. M., Norris J. G., Grenett H. E. and Fuller G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201212.
  • Boutin H., LeFeuvre R. A., Horai R., Asano M., Iwakura Y. and Rothwell N. J. (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21, 55285534.
  • Chen Y. and Swanson R. A. (2003) Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137149.
  • Chung I. Y. and Benveniste E. N. (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144, 29993007.
  • Corasaniti M. T., Bilotta A., Strongoli M. C., Navarra M., Bagetta G. and Di Renzo G. (2001) HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. Br. J. Pharmacol. 134, 13441350.
  • Da Cunha A., Jefferson J. A., Jackson R. W. and Vitkovic L. (1993) Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex. J. Neuroimmunol. 42, 7185.
  • Deshpande M., Zheng J., Borgmann K., Persidsky R., Wu L., Schellpeper C. and Ghorpade A. (2005) Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox. Res. 7, 183192.
  • Downen M., Amaral T. D., Hua L. L., Zhao M. L. and Lee S. C. (1999) Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28, 114127.
  • Flavin M. P., Zhao G. and Ho L. T. (2000) Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29, 347354.
  • Fogal B., Hewett J. A. and Hewett S. J. (2005) Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivation. J. Neuroimmunol. 161, 93100.
  • Ghorpade A., Holter S., Borgmann K., Persidsky R. and Wu L. (2003) HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J. Neuroimmunol. 141, 141149.
  • Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. III and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 76117615.
  • Hailer N. P., Vogt C., Korf H. W. and Dehghani F. (2005) Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur. J. Neurosci. 21, 23472360.
  • Hu S., Sheng W. S., Ehrlich L. C., Peterson P. K. and Chao C. C. (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7, 153159.
  • John G. R., Lee S. C., Song X., Rivieccio M. and Brosnan C. F. (2005) IL-1-regulated responses in astrocytes: Relevance to injury and recovery. Glia 49, 161176.
  • Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S. and Wang X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479489.
  • Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 14311568.
  • Ma X. C., Gottschall P. E., Chen L. T., Wiranowska M. and Phelps C. P. (2002) Role and mechanisms of interleukin-1 in the modulation of neurotoxicity. Neuroimmunomodulation 10, 1992077.
  • McCarthy K. D. and De Vellis J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890902.
  • Meucci O. and Miller R. J. (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 16, 40804088.
  • Peng Y. P., Qiu Y. H., Lu J. H. and Wang J. J. (2005) Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci. Lett. 374, 192196.
  • Pinteaux E., Parker L. C., Rothwell N. J. and Luheshi G. N. (2002) Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83, 754763.
  • Relton J. K. and Rothwell N. J. (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243246.
  • Rothwell N. (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152157.
  • Royston M. C., Rothwell N. J. and Roberts G. W. (1992) Alzheimer's disease: pathology to potential treatments? Trends Pharmacol. Sci. 13, 131133.
  • Schreck R., Rieber P. and Baeuerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 22472258.
  • Simi A., Porsmyr-Palmertz M., Hjerten A., Ingelman-Sundberg M. and Tindberg N. (2002) The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells. J. Neurochem. 83, 727737.
  • Sims J. E. (2002) IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol. 14, 117122.
  • Strijbos P. J. and Rothwell N. J. (1995) Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15, 34683474.
  • Viviani B., Bartesaghi S., Gardoni F. et al. (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 86928700.